SCHEMBL10168041

SCHEMBL10168041

COC(=O)COCCS(=O)(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ CA12 O43570 4/20 0.36
▸ CA14 Q9ULX7 4/20 0.36
▸ PTGS1 P23219 1/20 0.36
▸ PDE4A P27815 1/20 0.36
▸ MGAM O43451 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ SI P14410 1/20 0.34
▸ MGAM2 Q2M2H8 1/20 0.34
▸ FNTA P49354 1/20 0.33
▸ FNTB P49356 1/20 0.33
▸ CA7 P43166 2/20 0.33
▸ CA9 Q16790 2/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CYP2C19 P33261 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ LMNA P02545 2/20 0.31
▸ SLC6A6 P31641 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15426623 0.80 GAA (0.41) TSHRHSD17B10PTGS1PDE4AMGAM
SCHEMBL6463788 0.79 TSHR (0.50) TSHRHSD17B10CA12CA14MGAM
SCHEMBL16435375 0.79 TDP1 (0.37) TSHRHSD17B10PTGS1PDE4AALDH1A1
SCHEMBL7648165 0.77 TSHR (0.48) TSHRHSD17B10CA12CA14MGAM
SCHEMBL2853187 0.76 — —
SCHEMBL1335833 0.74 TSHR (0.56) TSHRHSD17B10CA12CA14MGAM
SCHEMBL418534 0.74 PTGS1 (0.53) TSHRPTGS1PDE4ACA2CYP2C19
SCHEMBL17923972 0.73 TSHR (0.36) TSHRHSD17B10CA12CA14PTGS1
SCHEMBL12092176 0.73 TSHR (0.43) TSHRHSD17B10CA12CA14MGAM
SCHEMBL4374105 0.73 TSHR (0.57) TSHRHSD17B10CA12CA14PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9023581-B2 Resist composition, method of forming resist pattern, polymeric compound, and compound TOKYO OHKA KOGYO CO., LTD (JP) 2015-05-05 — — US disclosed
US-20130089819-A1 RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, POLYMERIC COMPOUND, AND COMPOUND TOKYO OHKA KOGYO CO., LTD. (JP) 2013-04-11 — — US disclosed
US-20120015297-A1 RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, NOVEL COMPOUND, AND ACID GENERATOR TOKYO OHKA KOGYO.CO., LTD. (JP) 2012-01-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015297-A1 RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, NOVEL COMPOUND, AND ACID GENERATOR ASIC1, SLC11A2, RER1 TSHR 2459/4885HSD17B10 591/4885CA12 516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback